Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?-Reference-Cited by-同舟云学术

Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?

Published:2015-07-26 Issue:1 Volume:142 Page:201-212
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Carozzi Francesca,Tamburrino Lara,Bisanzi Simonetta,Marchiani Sara,Paglierani Milena,Di Lollo Simonetta,Crocetti Emanuele,Buzzoni Carlotta,Burroni Elena,Greco Luana,Baldi Elisabetta,Sani Cristina

Funder

Supported by Italian Ministry of Health

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-015-2015-1.pdf

Reference45 articles.

1. Albertsen PC, Hanley JA, Fine J (2005) 20-Year outcomes following conservative management of clinically localized prostate cancer. JAMA 293:2095–2101

2. Bastian PJ, Palapattu GS, Yegnasubramanian S, Lin X, Rogers CG, Mangold LA, Trock B, Eisenberger M, Partin AW, Nelson WG (2007) Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy. Clin Cancer Res 13:5361–5367

3. Berardi R, Morgese F, Onofri A, Mazzanti P, Pistelli M, Ballatore Z, Savini A, De Lisa M, Caramenti Rinaldi S, Pagliaretta S, Santoni M, Pierantoni C, Cascinu S (2013) Role of Maspin in cancer. Clin Transl Med 2:8

4. Bonaccorsi L, Nesi G, Nuti F, Paglierani M, Krausz C, Masieri L, Serni S, Proietti-Pannunzi L, Fang Y, Jhanwar SC, Orlando C, Carini M, Forti G, Baldi E, Luzzatto L (2009) Persistence of expression of the TMPRSS2:ERG fusion gene after pre-surgery androgen ablation may be associated with early prostate specific antigen relapse of prostate cancer: preliminary results. J Endocrinol Invest 32:590–596

5. Boxler S, Djonov V, Kessler TM, Hlushchuk R, Bachmann LM, Held U, Markwalder R, Thalmann GN (2010) Matrix metalloproteinases and angiogenic factors: predictors of survival after radical prostatectomy for clinically organ-confined prostate cancer? Am J Pathol 177:2216–2224

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients;Frontiers in Oncology;2023-02-28

2. The vulnerable primed cancer stem cells in disguise: demystifying the role of Maspin;Cancer and Metastasis Reviews;2022-12

3. Histologically benign PI‐RADS 4 and 5 lesions contain cancer‐associated epigenetic alterations;The Prostate;2021-10-21

4. The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review;International Journal of Molecular Sciences;2021-03-30

5. Advances in Prognostic Methylation Biomarkers for Prostate Cancer;Cancers;2020-10-15